Highlights and Quick Summary
- Revenue for the quarter ending September 30, 2023 was $744 Thousand (a -77.9% decrease compared to previous quarter)
- Year-over-year quarterly Revenue decreased by -52.22%
- Annual Revenue for 2022 was $5.75 Million (a 20.18% increase from previous year)
- Annual Revenue for 2021 was $4.78 Million (a 0.04% increase from previous year)
- Annual Revenue for 2020 was $4.78 Million (a 132.04% increase from previous year)
- Twelve month Revenue ending September 30, 2023 was $6.94 Million (a -18.98% decrease compared to previous quarter)
- Twelve month trailing Revenue increased by 20.71% year-over-year
Trailing Revenue for the last four month:
30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
---|---|---|---|
$6.94 Million | $8.56 Million | $6.2 Million | $5.75 Million |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Revenue of Absci Corporation
Most recent Revenueof ABSI including historical data for past 10 years.Interactive Chart of Revenue of Absci Corporation
Absci Corporation Revenue for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $0.74 | $3.37 | $1.27 | – | – |
2022 | $1.56 | $2.37 | $1.0 | $0.82 | $5.75 |
2021 | $1.45 | $1.54 | $0.73 | $1.06 | $4.78 |
2020 | $2.73 | $0.92 | $0.56 | $0.57 | $4.78 |
2019 | – | – | – | – | $2.06 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology